Boosted TTP Protein Cuts Frailty in 22-Month-Old Mice, Improving Strength and Bone Health
Updated
Updated · ScienceDaily · May 19
Boosted TTP Protein Cuts Frailty in 22-Month-Old Mice, Improving Strength and Bone Health
2 articles · Updated · ScienceDaily · May 19
22-month-old mice engineered to keep tristetraprolin, or TTP, stable showed lower frailty scores, stronger grip, better walking and endurance, and healthier bones than untreated animals.
TTP works by breaking down short-lived inflammatory RNA signals, and researchers say age-related declines in the protein may help drive the chronic low-grade inflammation known as inflammaging.
Male mice improved more than females, though both sexes developed stronger bones; the team said smaller body size and falling estrogen may have limited females' response.
$2.1 million in NIH funding supported the six-year project, published in Aging and Disease, which also found the treated mice had a more youthful immune profile.
Human therapies remain distant: early drug screens have not yet found a clear way to raise TTP, but researchers plan to test whether it could also curb neuroinflammation tied to dementia and Alzheimer's.
While a drug is years away, can lifestyle changes naturally boost the anti-aging protein TTP in our bodies?
This protein reversed aging in mice. Could it also be the key to fighting brain inflammation in Alzheimer's disease?
As scientists chase a 'fountain of youth' protein, could 'zombie' cells be the real cause of age-related decline?
Targeting Tristetraprolin (TTP) to Combat Age-Related Frailty and Inflammation: Breakthroughs, Mechanisms, and Future Directions
Overview
Recent research highlights the promise of tristetraprolin (TTP) in fighting aging by suppressing chronic inflammation, a key driver of age-related decline. In aged mice, stabilizing TTP mRNA leads to remarkable improvements, including stronger bones, reduced frailty, and better overall health. By manipulating TTP levels, scientists can reverse frailty and promote healthier aging. These findings suggest that TTP acts as a natural brake on inflammation, offering a new approach to combat the negative effects of aging and improve quality of life. While results are encouraging, more work is needed before human treatments become available.